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Supplementary Table 1: Prevalence of Blindness and Visual Impairment (VI) Based on the World Health Organization 
Definition.* 
    Based on Presenting Visual Acuity   Based on Best-Corrected Visual Acuity  
 Age group, years All (N=3,353)  Male (N=1,662) 
Female 
(N=1,691) 
 
All (N=3,353) 
Male 
(N=1,662) 
Female 
(N=1,691) 
Vision status#  n, (%) n, (%) n, (%)  n, (%) n, (%) n, (%) 
Bilateral 
blindness   
40-49  0 (0.0) 0 (0.0) 0 (0.0)  0 (0.0) 0 (0.0) 0 (0.0) 
50-59 0 (0.0) 0 (0.0) 0 (0.0)  0 (0.0) 0 (0.0) 0 (0.0) 
60-69 2 (0.2) 1 (0.2) 1 (0.2)  1 (0.1) 1 (0.2) 0 (0.0) 
70+ 5 (0.8) 1 (0.3) 4 (1.4)  3 (0.5) 1 (0.3) 2 (0.7) 
Total 7 (0.2) 2 (0.1) 5 (0.3)  4 (0.1) 2 (0.1) 2 (0.1) 
Age standardised 
prevalence, % (95% 
CI)† 0.2 (0.1–0.4) 0.1 (0.0–0.5) 0.3 (0.1–0.7) 
 
0.1 (0.0–0.3) 0.1 (0.0–0.5) 0.1 (0.0–0.5) 
         
Bilateral 
visual 
impairment^     
40-49 27 (3.8) 13 (3.8) 14 (3.9)  1 (0.1) 0 (0.0) 1 (0.3) 
50-59 43 (3.8) 19 (3.8) 24 (3.9)  4 (0.4) 2 (0.4) 2 (0.3) 
60-69 87 (9.7) 42 (8.9) 45 (10.6)  9 (1.0) 4 (0.8) 5 (1.2) 
70+ 155 (24.5) 80 (23.9) 75 (25.3)  42 (6.7) 19 (5.7) 23 (7.8) 
Total 312 (9.3) 154 (9.3) 158 (9.3)  56 (1.7) 25 (1.5)  31 (1.8) 
Age standardised 
prevalence, % (95% 
CI)† 7.8 (6.7–9.2) 7.1 (5.6–9.1) 8.5 (6.8–10.8) 
 
1.3 (0.9–1.9) 1.0 (0.6–1.9) 1.7 (1.0–2.9) 
         
Unilateral 
blindness 
40-49 6 (0.9) 4 (1.2) 2 (0.6)  4 (0.6) 2 (0.6) 2 (0.56) 
50-59 11 (1.0) 2 (0.4) 9 (1.48)  9 (0.81) 1 (0.2) 8 (1.3) 
60-69 25 (2.8) 18 (3.8) 7 (1.64)  18 (2.0) 14 (2.95) 4 (0.9) 
70+ 23 (3.6) 16 (4.76) 7 (2.36)  31 (4.91) 21 (6.25) 10 (3.4) 
Total 65 (1.9) 40 (2.4) 25 (1.5)  62 (1.8) 38 (2.3) 24 (1.4) 
Age standardised 
prevalence, % (95% 
CI)† 1.7 (1.3–2.2) 1.8 (1.3–2.6) 1.3 (0.9–2.1) 
 
1.5 (1.2–2.0) 1.6 (1.1–2.3) 1.3 (0.8–2.0) 
         
Unilateral 
visual 
impairment    
40-49 60 (8.5) 24 (6.88) 36 (9.97)  9 (1.27) 6 (1.72) 3 (0.83) 
50-59 138 (12.4) 55 (10.93) 83 (13.65)  14 (1.26) 8 (1.59) 6 (0.99) 
60-69 153 (17.0) 86 (18.14) 67 (15.73)  47 (5.22) 28 (5.91) 19 (4.46) 
70+ 168 (26.6) 86 (25.6) 82 (27.7)  85 (13.45) 47 (13.99) 38 (12.84) 
Total 519 (15.5) 251 (15.1) 268 (15.8)  155 (4.6) 89 (5.4) 66 (3.9) 
Age standardised 
prevalence, % (95% 
CI)† 13.9 (12.7–15.2) 12.6 (11.0–14.5) 15.0(13.2–17.1) 
 
3.7 (3.1–4.4) 4.0 (3.1–5.0) 3.5 (2.7–4.5) 
*Based on the WHO definition, VI was defined as VA <20/60 to ≥20/400. Blindness was defined as VA <20/400. 
#Bilateral blindness and bilateral VI were defined based on better-seeing eye, while unilateral blindness and unilateral VI were defined based on 
worse-seeing eye.  
^ Bilateral VI includes participants with VI in one eye and VI/ blindness in the other eye. 
†Standardised to Singapore Chinese population 2010 census.  
